Is cycc going up any time soon

Cyclacel Pharmaceuticals (CYCC) is unlikely to experience an immediate price increase. Here's why:

1. Current Price Trend: The stock is in a bearish trend, which has persisted for 22 days. This suggests that the downward pressure on the stock is likely to continue in the near term
2. Support and Resistance Levels: CYCC is currently positioned between narrow resistance and wide resistance levels, indicating that while there is some resistance, it may not be strong enough to prevent further declines. The stock is also between narrow support and wide support levels, which could mean that any upward movement is likely to face resistance
3. Forecasted Price Trend: The forecast for CYCC is bearish, with a 53.4% historical win rate for this type of forecast. This means that based on past performance, the stock is more likely to continue its current trend than to reverse direction
4. Recent Performance: CYCC has experienced a significant decline, with a price drop of 94.4% in the past year. The stock's market capitalization has shrunk, and it has been subject to volatile trading activity, including a substantial increase in trading volume.
5. Volume and Price Movement: The trading volume on June 5, 2025, was 5.5 million shares, which is a notable indicator of market activity. However, without additional context on why the volume is high, it